The Association Between Existing Health Conditions and Adverse Events From Botulinum Toxins: Findings From a UK Cross-sectional Survey in 2024.
Abstract
[BACKGROUND] There is growing demand for Botulinum toxin (BoNT) injections in the UK. However, there is a scarcity of research in relation to associations between medical conditions and BoNT adverse events.
[OBJECTIVES] To investigate cross-sectional associations between existing medical conditions and the likelihood of adverse events in a large sample of UK BoNT users.
[METHODS] A cross-sectional observational survey on individuals' (≥18 years) experiences and adverse events with cosmetic BoNT injections. Data were collected on participants age, gender, existing health conditions, acute and long-term adverse events following BoNT treatment. To investigate the association between pre-existing physical conditions and the occurrence of post-BoNT adverse effects, multivariable logistic regression models were performed.
[RESULTS] Nine hundred and nineteen participants who received BoNT were included in the analysis. Multivariable logistic regression revealed that several pre-existing physical and psychiatric conditions were significantly associated with increased odds of specific post-BoNT adverse effects. Notably, individuals with skin disease (odds ratio [OR] 22.95, 95% confidence interval [CI] 2.64-132.03, P = .001), type 1 diabetes mellitus (OR 110.34, 95% CI 3.85-3381.06, P = .002), chronic migraine (OR 7.69, 95% CI 1.84-27.61, P = .003), and thyroid disorders (OR 6.18, 95% CI 1.27-23.44, P = .012) demonstrated significantly higher odds of developing nausea following BoNT administration. Multiple other significant associations were found between numerous existing health conditions and numerous adverse events.
[CONCLUSIONS] This study found that autoimmune, endocrine, neurological, and mental health comorbidities significantly increase the likelihood of adverse outcomes, ranging from bruising and ptosis to mood disturbance, neuromuscular weakness, and apparent treatment failure.
[OBJECTIVES] To investigate cross-sectional associations between existing medical conditions and the likelihood of adverse events in a large sample of UK BoNT users.
[METHODS] A cross-sectional observational survey on individuals' (≥18 years) experiences and adverse events with cosmetic BoNT injections. Data were collected on participants age, gender, existing health conditions, acute and long-term adverse events following BoNT treatment. To investigate the association between pre-existing physical conditions and the occurrence of post-BoNT adverse effects, multivariable logistic regression models were performed.
[RESULTS] Nine hundred and nineteen participants who received BoNT were included in the analysis. Multivariable logistic regression revealed that several pre-existing physical and psychiatric conditions were significantly associated with increased odds of specific post-BoNT adverse effects. Notably, individuals with skin disease (odds ratio [OR] 22.95, 95% confidence interval [CI] 2.64-132.03, P = .001), type 1 diabetes mellitus (OR 110.34, 95% CI 3.85-3381.06, P = .002), chronic migraine (OR 7.69, 95% CI 1.84-27.61, P = .003), and thyroid disorders (OR 6.18, 95% CI 1.27-23.44, P = .012) demonstrated significantly higher odds of developing nausea following BoNT administration. Multiple other significant associations were found between numerous existing health conditions and numerous adverse events.
[CONCLUSIONS] This study found that autoimmune, endocrine, neurological, and mental health comorbidities significantly increase the likelihood of adverse outcomes, ranging from bruising and ptosis to mood disturbance, neuromuscular weakness, and apparent treatment failure.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | skin
|
scispacy | 1 | ||
| 해부 | thyroid
|
scispacy | 1 | ||
| 해부 | neuromuscular
|
scispacy | 1 | ||
| 약물 | BoNT
→ Botulinum toxin
|
C0006055
Botulinum Toxins
|
scispacy | 1 | |
| 약물 | [BACKGROUND]
|
scispacy | 1 | ||
| 약물 | [OBJECTIVES]
|
scispacy | 1 | ||
| 약물 | CI 3.85
|
scispacy | 1 | ||
| 약물 | CI 1.27-23.44
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS]
|
scispacy | 1 | ||
| 질환 | cosmetic BoNT
|
scispacy | 1 | ||
| 질환 | psychiatric
|
C0033873
Psychiatry Specialty
|
scispacy | 1 | |
| 질환 | skin disease
|
C0037274
Dermatologic disorders
|
scispacy | 1 | |
| 질환 | diabetes mellitus
|
C0011849
Diabetes Mellitus
|
scispacy | 1 | |
| 질환 | migraine
|
C0149931
Migraine Disorders
|
scispacy | 1 | |
| 질환 | thyroid disorders
|
C0040128
Thyroid Diseases
|
scispacy | 1 | |
| 질환 | nausea
|
C0027497
Nausea
|
scispacy | 1 | |
| 질환 | autoimmune, endocrine, neurological, and mental health comorbidities significantly increase the likelihood of adverse outcomes, ranging from bruising
|
scispacy | 1 | ||
| 질환 | ptosis to mood disturbance
|
scispacy | 1 | ||
| 질환 | neuromuscular weakness
|
scispacy | 1 | ||
| 기타 | Botulinum Toxins
|
scispacy | 1 | ||
| 기타 | BoNT
→ Botulinum toxin
|
scispacy | 1 | ||
| 기타 | UK BoNT
|
scispacy | 1 | ||
| 기타 | participants
|
scispacy | 1 |
MeSH Terms
Humans; Cross-Sectional Studies; Male; Female; United Kingdom; Middle Aged; Adult; Cosmetic Techniques; Botulinum Toxins; Young Adult; Aged; Neuromuscular Agents; Adolescent
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.